Successful use of bivalirudin for superior vena cava recanalization and stent placement in a child with heparin-induced thrombocytopenia

Pediatric Cardiology

Volumn 29, Issue 4, 2008, Pages 804-807

  Breinholt, John P ^a   Moffett, Brady S ^a   Texter, Karen M ^a   Ing, Frank F ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Anticoagulation; Congenital heart disease; Thrombosis

Indexed keywords

HEPARIN; HIRULOG; WARFARIN;

ANGIOPLASTY; ANTICOAGULANT THERAPY; AORTA VALVE REPLACEMENT; ARTICLE; CASE REPORT; CONGENITAL HEART DISEASE; DRUG WITHDRAWAL; GLENN SHUNT; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRESCHOOL CHILD; RECANALIZATION; STENT; SUPERIOR CAVA VEIN; SUPERIOR CAVA VEIN OBSTRUCTION; TRICUSPID VALVE REGURGITATION;

ANGIOPLASTY, BALLOON; ANTICOAGULANTS; CHILD, PRESCHOOL; HEART DEFECTS, CONGENITAL; HEPARIN; HIRUDINS; HUMANS; MALE; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; RECURRENCE; STENTS; SUPERIOR VENA CAVA SYNDROME; THROMBOCYTOPENIA;

EID: 46749104466     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-008-9231-2     Document Type: Article

References (23)

1. Almond CS, Harrington J, Thiagarajan R et al (2006) Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia. J Heart Lung Transplant 25:1376-1379
2. Arepally GM, Ortel TL (2006) Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 355:809-817
3. Chew DP, Lincoff AM, Gurm H et al (2005) Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial). Am J Cardiol 95:581-585
4. Freed MD, Keane JF, Rosenthal A (1974) The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation 50:565-569
5. Girolami B, Prandoni P, Stefani PM et al (2003) The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood 101:2955-2959
6. Huebler M, Koster A, Buz S et al (2006) Cardiopulmonary bypass for complex cardiac surgery using bivalirudin anticoagulation in a patient with heparin antibodies. J Card Surg 21:286-288
7. Katzen BT, Ardid MI, MacLean AA et al (2005) Bivalirudin as an anticoagulation agent: safety and efficacy in peripheral interventions. J Vasc Interv Radiol 16:1183-1187, quiz 7
8. Koster A, Dyke CM, Aldea G et al (2007) Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial. Ann Thorac Surg 83:572-577
9. Koster A, Spiess B, Chew DP et al (2004) Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol 93:356-359
10. Koster A, Spiess B, Jurmann M et al (2006) Bivalirudin provides rapid, effective, and reliable anticoagulation during off-pump coronary revascularization: results of the "EVOLUTION OFF" trial. Anesth Analg 103:540-544
11. Koster A, Weng Y, Bottcher W, Gromann T, Kuppe H, Hetzer R (2007) Successful use of bivalirudin as anticoagulant for ECMO in a patient with acute HIT. Ann Thorac Surg 83:1865-1967
12. Lincoff AM, Bittl JA, Harrington RA et al (2003) Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 289:853-863
13. Lincoff AM, Kleiman NS, Kereiakes DJ et al (2004) Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA 292:696-703
14. Murphy GS, Marymont JH (2007) Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery. J Cardiothorac Vasc Anesth 21:113-126
15. Pappalardo F, Franco A, Crescenzi G, Poli A, Zangrillo A, Koster A (2007) Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin allergy. Perfusion 22:67-69
16. Ranze O, Ranze P, Magnani HN, Greinacher A (1999) Heparin-induced thrombocytopenia in paediatric patients-a review of the literature and a new case treated with danaparoid sodium. Eur J Pediatr 158(Suppl 3):S130-S133
17. Risch L, Huber AR, Schmugge M (2006) Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children. Thromb Res 118:123-135
18. Seybert AL, Coons JC, Zerumsky K (2006) Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin? Pharmacotherapy 26:229-241
19. Shammas NW, Allie D, Hall P et al (2005) Predictors of in-hospital and 30-day complications of peripheral vascular interventions using bivalirudin as the primary anticoagulant: results from the APPROVE Registry. J Invasive Cardiol 17:356-359
20. Shammas NW, Lemke JH, Dippel EJ et al (2003) Bivalirudin in peripheral vascular interventions: a single center experience. J Invasive Cardiol 15:401-404
21. Stone GW, White HD, Ohman EM et al (2007) Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet 369:907-919
22. Weitz JI, Bates SM (2002) Acute coronary syndromes: a focus on thrombin. J Invasive Cardiol 14(Suppl B):2B-7B
23. Young G, Tarantino MD, Wohrley J, Weber LC, Belvedere M, Nugent DJ (2007) Pilot dose-finding and safety study of bivalirudin in infants <6 months of age with thrombosis. J Thromb Haemost 5:1654-1659